Chronic Recurrent Multifocal Osteomyelitis

Med Clin North Am. 2024 Jan;108(1):227-239. doi: 10.1016/j.mcna.2023.05.022. Epub 2023 Jul 11.

Abstract

Chronic recurrent multifocal osteomyelitis (CRMO) is an underrecognized autoinflammatory disease affecting the skeletal system. Its vague symptoms are often first attributed to growing pains, infection, or malignancy, which can lead to a delay in diagnosis for days to years. Untreated CRMO has the potential to cause debilitating skeletal deformities, arthritis, and chronic pain; hence early recognition and treatment are paramount. MRI is the gold standard for diagnosis. Treatment consists of various antiinflammatory medications and may also include bisphosphonates if vulnerable skeletal sites are involved. Even when treated, the disease may have a relapsing course lasting years.

Keywords: Bone pain; CNO; CRMO; Chronic recurrent multifocal osteomyelitis; Whole-body MRI.

Publication types

  • Review

MeSH terms

  • Chronic Disease
  • Diphosphonates / therapeutic use
  • Humans
  • Magnetic Resonance Imaging
  • Osteomyelitis* / diagnostic imaging
  • Osteomyelitis* / drug therapy

Substances

  • Diphosphonates

Supplementary concepts

  • Chronic recurrent multifocal osteomyelitis